The coming legalization of recreational marijuana is already increasing funding for studies, but regulations on such research have been slow to change.

As the CBD-based medication enters the market, the agency promises a crackdown on producers of cannabidiol products that make unproven claims.

Marijuana ointments as cancer treatments remain a distant prospect. 

Researchers suspect the source of the toxins may be some of the state’s 50,000 or so marijuana farms.

And the same endocannabinoid system that translates marijuana's buzz-inducing compounds into a high plays crucial roles in health and disease outside the brain.

Around 40 percent of children with an uncommon disorder had 50 percent fewer seizures while taking the marijuana derivative.

In young mice, THC had the opposite effect.

Academics partner with a biotech firm to investigate cannabinoids and develop potential therapeutics.

US scientists continue to have a hard time getting funding to study the health impacts of the drug. But cannabis research in Canada—where medical marijuana is legal nationwide—is different story.